Veritone, Inc. Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2022

As of March 31, 2022, the Company’s cash and cash equivalents were as follows:

As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows:

As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:


			Changes in					Fair		Contingent
	Cost		Fair Value		Amount Paid			Value		Consideration
	(As Restated)		(As Restated)		In Period			(As Restated)		(As Restated)
Level 3:
Contingent consideration, current	$	18,128	$	2,822	$	(20,816	)	$	134	$	134
Contingent consideration, non-current		21,384		14,297		—			35,681		35,681
Total	$	39,512	$	17,119	$	(20,816	)	$	35,815	$	35,815

As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in		Fair		Contingent
	Cost		Fair Value		Value		Consideration
Level 3:
Contingent consideration, current	$	18,128	$	1,925	$	20,053	$	20,053
Contingent consideration, non-current		21,384		10,149		31,533		31,533
Total	$	39,512	$	12,074	$	51,586	$	51,586